博腾股份 (300363)

Porton Pharma Solutions Ltd.

ASZ

Tags

Contract Research Organization (CXO)ImmunotherapyWeight Loss DrugsInnovative DrugsPharmaceutical ManufacturingOverseas BusinessMargin Trading and Securities LendingChiNext 200 IndexChiNext 300 IndexChiNext HealthcareChiNext Tech

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 54344.22
  • Circulating A-Shares(W): 49885.64
  • Earnings Per Share(RMB): 0.1500
  • Net Assets Per Share(RMB): 9.7803
  • Operating Revenue(W RMB): 254442.50
  • Total Profit(W RMB): 6216.20
  • Net Profit Attributable to Parent(W RMB): 7991.54
  • Net Profit Growth Rate(%): 138.71
  • Weighted Return on Equity(%): 1.5200
  • Operating Cash Flow Per Share(RMB): 0.6880
  • Undistributed Profit Per Share(RMB): 4.6736
  • Capital Reserve Per Share(RMB): 3.7419

2. Main Business

The main business covers:

  • Small molecule API business
  • Small molecule preparation business
  • Gene and cell therapy business
  • New molecule business

3. Company Basic Information

  • Company Name: Porton Pharma Solutions Ltd.
  • Listing Date: 2014-01-29
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 7 Yuntu Road, Beibei District, Chongqing, China
  • Website: www.portonpharma.com
  • Company Profile: The issuer was established by the overall change of Chongqing Porton Fine Chemicals Co., Ltd. into a joint stock company. On November 27, 2009, with the unanimous consent of all sponsors at the inaugural meeting and the first shareholders' meeting, based on the audited net assets of Porton Limited of RMB 89,959,142.75 as of September 30, 2009, RMB 70,000,000 was converted into 70,000,000 shares at a 1:1 ratio, and the balance of RMB 19,959,142.75 was recorded as capital reserve. On December 16, 2009, the issuer completed the industrial and commercial change registration at the Changshou District Branch of the Chongqing Administration for Industry and Commerce, obtained the "Business License of Enterprise Legal Person", with a registered capital of RMB 70,000,000.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Chongqing Liangjiang New Area Industrial Development Group Co., Ltd. General Legal Person 7898.27 15.78
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 2397.76 4.79
3 Tianhong Pharmaceutical Innovation Hybrid Securities Investment Fund A Class Fund 593.96 1.19
4 National Social Security Fund 413 Portfolio Social Security Fund 407.43 0.81
5 Hua'an Juyou Jingxuan Hybrid Securities Investment Fund Fund 377.75 0.75
6 Southern China Securities 1000 ETF Fund 299.75 0.60
7 Changsheng Transformation and Upgrading Theme Flexible Allocation Hybrid Securities Investment Fund Fund 33.41 0.07
8 Fuanda Pharmaceutical Innovation Hybrid Securities Investment Fund Fund 19.79 0.04
9 GF Hengxiang Bond Securities Investment Fund A Class Fund 12.56 0.03
10 Morgan Stanley Youyue Anhe Hybrid Securities Investment Fund A Class Fund 8.75 0.02

5. Concept Sectors

  • Immunotherapy
  • CXO Concept
  • Innovative Drugs
  • Weight Loss Drugs
  • Margin Trading & Securities Lending
  • Overseas Business
  • Chuangye 300 Index
  • Chuangkeji Index
  • Chuangyiyao Index
  • Chuangye 200 Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information